Related Experiment Video
Updated: Jun 6, 2026

Exploring Sequence Space to Identify Binding Sites for Regulatory RNA-Binding Proteins
Published on: August 9, 2019
pPKCδ activates SC35 splicing factor during H9c2 myoblastic differentiation
Susi Zara1, Mirella Falconi, Monica Rapino
1Department of Drug Sciences, Faculty of Pharmacy, University G d'Annunzio, Chieti-Pescara, Italy. s.zara@unich.it
Abstract:
Although Protein Kinase C (PKC) isoforms' role in the neonatal and adult cardiac tissue development and ageing has been widely described "in vivo", the interaction of such enzymes with specific nuclear substrates needs to be investigated. The aim of our research has been the study of the expression, localization and interaction with the splicing factor SC35 of PKC isoforms (α, δ, ε, ζ) and their potential role in modulating the transcription machinery. H9c2 cells induced to myoblast differentiation in the presence of 1% Horse Serum (HS) have represented our experimental model. The expression of PKC isoforms, their distribution and interaction with SC35 have been evaluated by western blotting, co-immunoprecipitation and double gold immunolabeling for transmission and scanning electron microscopy. Our results show PKCδ as the most expressed isoform in differentiated cells. Surprisingly, the distribution of PKCδ and SC35 does not show any significant modification between 10%FBS and 1%HS treated samples and no co-localization is observed. Moreover the interaction between the phosphorylated form of PKCδ (pPKCδ) and SC35 increases, is distributed and co-localizes within the nucleus of differentiated H9c2. These data represent reasonable evidence of pPKCδ mediated SC35 splicing factor activation, suggesting its direct effect on transcription via interaction with the transcription machinery. Furthermore, this co-localization represents a crucial event resulting in downstream changes in transcription of components which determine the morphological modifications related to cardiomyoblast differentiated phenotype.
Insights
Phosphorylated Protein Kinase C delta (pPKCδ) interacts with splicing factor SC35 in the nucleus, activating transcription and influencing cardiomyoblast differentiation. This PKCδ-SC35 interaction is key to cardiac cell development.
Area of Science:
- Cell Biology
- Molecular Biology
- Cardiovascular Research
Background:
- Protein Kinase C (PKC) isoforms are crucial for cardiac development and aging.
- The nuclear interactions of PKC isoforms with specific substrates, like splicing factors, remain understudied.
Purpose of the Study:
- Investigate the expression, localization, and interaction of PKC isoforms (α, δ, ε, ζ) with splicing factor SC35.
- Determine the role of PKC isoforms in modulating the transcription machinery during cardiomyoblast differentiation.
Main Methods:
- Utilized H9c2 cells induced to myoblast differentiation.
- Employed western blotting, co-immunoprecipitation, and electron microscopy for analysis.
- Assessed expression, distribution, and interaction of PKC isoforms and SC35.
Main Results:
- PKCδ was the most expressed isoform in differentiated H9c2 cells.
- Phosphorylated PKCδ (pPKCδ) showed increased nuclear interaction and co-localization with SC35.
- No significant changes in PKCδ and SC35 distribution were observed between different serum conditions.
Conclusions:
- pPKCδ activation of SC35 suggests a direct role in modulating transcription via nuclear interaction.
- The pPKCδ-SC35 nuclear co-localization is critical for downstream transcriptional changes.
- This interaction influences morphological modifications associated with cardiomyoblast differentiation.
Related Concept Videos
Master Transcription Regulators
Alternative RNA Splicing
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
TGF - β Signaling Pathway
Anaphase Promoting Complex
Pre-mRNA Processing: RNA Splicing
Cell Specific Gene Expression

